Unlock instant, AI-driven research and patent intelligence for your innovation.

Novel medical use of 2 alpha, 23- dihydroxyl ursolic acid

A technology of dihydroxyursulic acid and application, applied in the field of medicine, can solve the problems of no hepatocyte protection effect, no clinical application, etc.

Inactive Publication Date: 2005-09-21
NANJING UNIV
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

There is no report on the treatment of diseases, and there is no report on the protection of liver cells, nor is it clinically applied

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel medical use of 2 alpha, 23- dihydroxyl ursolic acid
  • Novel medical use of 2 alpha, 23- dihydroxyl ursolic acid

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0018] Measurement of mitochondrial swelling

[0019] Preparation of mitochondria and measurement of mitochondrial swelling. According to the Appril method, the liver was separated in the pre-cooled separation solution (including 0.225mol·L -1 Mannitol, 0.075mol L -1 Sucrose, 0.05mmol·L -1 EDTA, 10mmol·L -1 Tris-HCl, pH 7.4), cut into pieces, washed, homogenized, centrifuged at 500×g for 5 minutes, took the supernatant, centrifuged at 8800×g for 10 minutes, discarded the supernatant, the precipitate was the mitochondria, and used the separation solution Wash 3 times and finally resuspend in separation medium. Protein concentration was determined by the Coomassie brilliant blue method.

[0020] Mitochondria were resuspended in the assay solution (125mmol·L -1 Sucrose, 50mmol·L -1 KCl, 2mmol L -1 K H 2 PO 4 , 5mmol·L -1 Succinic acid, 50μmol·L -1 CaCl 2 , 5 μmol L -1 Rotenone, 10mmol·L -1 Hepes, pH7.4). Normal mouse liver mitochondria were divided into 6 gr...

Embodiment 2

[0023] Determination of Superoxide Anion Scavenging Rate

[0024] The scavenging effect of 2,23-hydroxyursolic acid on superoxide anion was detected by xanthine / xanthine oxidase oxygen radical generation system. In 3mL 10mmol·L -1 K H 2 Add 50μmol·L to PO4-KOH buffer (pH7.4) -1 , 150μmol·L -1 , 500μmol·L -1 2α, 23-Dihydroxyursolic acid, 100 μmol L -1 Xanthine and 0.02 U / mL xanthine oxidase, add nitroblue tetrazolium (NBT) 100 μmol L -1 , incubated at 25°C for 5min, and measured the absorbance at 550nm. With 500μmol·L -1 Oleanolic acid was used as a positive control. The formula for calculating superoxide anion scavenging rate is as follows: (ΔA control -ΔA drug ) / ΔA control ×100%, ΔA=A 0min -A 5min .

[0025] Table 1 Scavenging effect of 2,23-dihydroxyursolic acid on superoxide anion produced by xanthine / xanthine oxidase system.

[0026] Group Absorbance decrease (ΔA) Clearance

[0027] Control 242.00±16.86

[0028] Oleanolic acid 500μmol·L -1 147.00...

Embodiment 3

[0035] Determination of hydroxyl radical scavenging rate

[0036] Using CuSO 4 / Cytochrome C free radical generation system detects the scavenging effect of DHUA on hydroxyl free radicals. In 3mL 0.15mmol·L -1 Phosphate buffer (containing 100 μmol L -1 VitC, 100μmol·L -1 CuSO 4 and 100μmol·L -1 Cytochrome C, pH 7.4) was added with 50 μmol L -1 , 150μmol·L -1 , 500μmol·L -1 Ursolic acid or DHUA, the reaction system was incubated at 25°C for 90 minutes, and the absorbance value was measured at 550nm, with 500μmol L -1 Oleanolic acid was used as a positive control. The calculation formula of hydroxyl radical scavenging rate is the same as above, where, ΔA=A 0min -A 90min .

[0037] Table 2 Effect of 2,23-dihydroxyursolic acid on vitamin C / CuSO 4 The scavenging effect of hydroxyl radicals generated by the system.

[0038] Group Absorbance decrease (ΔA) Clearance

[0039] Control 442.83±23.42

[0040] Oleanolic acid 500μmol·L -1 241.33±27.21 45.6%

[0041]...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the field of natural medicament, in particular, the invention discloses the medicinal use of 2 alpha, 23-dihydroxy ursolic acid in hepatocyte protection, and use in the treatment and / or prevention of diseases such as liver damage, hepatitis, hepatic carcinoma and cirrhosis.

Description

[0001] Technical Field The present invention relates to the field of medicine, and discloses a new medical application of 2α, 23-dihydroxyursolic acid, that is, a new medical application for protecting liver cells and preventing and treating liver diseases. Background technique [0002] 2α, 23-dihydroxyursolic acid, full name 2α, 3β, 23-trihydroxyursane-28-acid, commonly known as 2, 23-dihydroxyursolic acid, English name 2α, 3β, 23-trihydroxyurs- 12-en-28-oic acid (DHUA for short), with the following structural formula, is an active ingredient present in plants such as Terminalia asiatica and Rhoccloclenclron japonicum. There is no report on the treatment of diseases, let alone the report on the protection of liver cells, and it has not been applied clinically. [0003] [0004] R 1 R 2 [0005] ursolic acid (UA) (ursolic acid) H CH 3 [0006] 2α, 3β, 23-trihydroxyurs-12-en-28-oic acid (DHUA...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/56A61P1/16A61P31/12
Inventor 汤新慧高静赵晓宁范怡梅徐力致王勇杨晓荷窦环王燕萍朱俐
Owner NANJING UNIV